SCHEDULE 13G//SEC Filing
Maze Therapeutics, Inc. SCHEDULE 13G
Accession 0000902664-25-002323
CIK 0001410830other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:10 PM ET
Size
13.1 KB
Accession
0000902664-25-002323
Issuer
Matrix Capital Management Company, LP
CIK 0001410830
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001410830
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:10 PM ET
- Size
- 13.1 KB